FIBROSpect® NASH serum test identifies advanced liver fibrosis in patients with nonalcoholic steatohepatitis: Results of a validation study

被引：3
|
作者：
Abdelmalek, M. [1 ]
Guy, C. [1 ]
Diehl, A. M. [1 ]
Li, X. [2 ]
Mimms, L. [2 ]
Hester, K. [2 ]
Jain, A. [2 ]
Loomba, R. [3 ]
机构：
[1] Duke Univ, Div Gastroenterol, Durham, NC USA
[2] Prometheus Labs Inc, Res & Dev, San Diego, CA USA
[3] Univ Calif San Diego, Div Gastroenterol, San Diego, CA 92103 USA
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)31400-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-462
引用
收藏
页码：S571 / S572
页数：2
相关论文
共 50 条
  • [1] Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis
    Loomba, Rohit
    Jain, Anjali
    Diehl, Anna Mae
    Guy, Cynthia D.
    Portenier, Dana
    Sudan, Ranjan
    Singh, Seema
    Faulkner, Claire
    Richards, Lisa
    Hester, Kelly D.
    Okada, Lauren
    Li, Xiao-jun
    Mimms, Larry
    Abdelmalek, Manal F.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (09) : 1867 - +
  • [2] Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis
    Harrison, Stephen A.
    Abdelmalek, Manal F.
    Diehl, Anna Mae
    Caldwell, Stephen
    Shiffman, Mitchell L.
    Ghalib, Reem
    Lawitz, Eric
    Rockey, Don C.
    Schall, Raul E. Aguilar
    Jia, Catherine
    McColgan, Bryan J.
    Myers, Robert P.
    Subramanian, Mani
    McHutchison, John G.
    Muir, Andrew J.
    Ratziu, Vlad
    Afdhal, Nezam H.
    Goodman, Zachary D.
    Bosch, Jaime
    Sanyal, Arun J.
    HEPATOLOGY, 2017, 66 : 1120A - 1121A
  • [3] Serum markers of fibrogenesis and fibrosis in nonalcoholic steatohepatitis (NASH).
    Costanzo, M
    Miele, L
    Di Rocco, P
    Forgione, A
    Alfei, B
    Pompili, M
    Rapaccini, GL
    Grieco, A
    Gasbarrini, G
    HEPATOLOGY, 2002, 36 (04) : 412A - 412A
  • [4] IDENTIFICATION OF SERUM METABOLITES AS DIAGNOSTIC BIOMARKERS FOR ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH)
    Anstee, Quentin M.
    Lawitz, Eric J.
    Alkhouri, Naim
    Wong, Vincent Wai-Sun
    Romero-Gomez, Manuel
    Okanoue, Takeshi
    Trauner, Michael H.
    Chuang, Jay
    Billin, Andrew
    Wang, Ya
    Chen, Guang
    Myers, Robert P.
    Djedjos, Stephen
    Goodman, Zackary
    Harrison, Stephen A.
    Younossi, Zobair M.
    HEPATOLOGY, 2019, 70 : 1042A - 1042A
  • [5] Characterization of insulin resistance in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH)
    Ratziu, Vlad
    Sanyal, Arun J.
    Loomba, Rohit
    Caldwell, Stephen H.
    Ghalib, Reem H.
    Torres, Dawn M.
    McCullough, Arthur J.
    Muir, Andrew J.
    Myers, Robert P.
    Schall, Raul E. Aguilar
    Subramanian, Mani
    McHutchison, John G.
    Bosch, Jaime
    Harrison, Stephen A.
    Abdelmalek, Manal F.
    HEPATOLOGY, 2015, 62 : 1298A - 1299A
  • [6] IMPACT OF MODEST WEIGHT REDUCTION ON SERUM MARKERS, LIVER HISTOLOGY, AND DISEASE PROGRESSION IN PATIENTS WITH ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH)
    Bosch, Jaime
    Harrison, Stephen A.
    Ratziu, Vlad
    Anstee, Quentin M.
    Trauner, Michael H.
    Lawitz, Eric J.
    Wong, Vincent Wai-Sun
    Okanoue, Takeshi
    Romero-Gomez, Manuel
    Shiffman, Mitchell L.
    Caldwell, Stephen
    Ma, Lily
    Ding, Dora
    Huss, Ryan
    Chung, Chuhan
    Myers, Robert P.
    Goodman, Zachary
    Afdhal, Nezam H.
    Younossi, Zobair M.
    Sanyal, Arun J.
    HEPATOLOGY, 2021, 74 : 155A - 156A
  • [7] Identification and Characterization of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients with Advanced Liver Fibrosis Identified Using Noninvasive Test (NIT) of Hepatic Fibrosis: Real-World Results of 3,421 Patients
    Younossi, Zobair M.
    Shreay, Sanatan
    Parker, Emily
    Loomba, Rohit
    HEPATOLOGY, 2018, 68 : 614A - 615A
  • [8] Serum Somascan Proteomics Identifies Serum Biomarkers of Advanced Fibrosis in Nash Patients
    Luo, Yi
    Charles, Edgar D.
    Oseini, Abdul M.
    Collen, Rebecca
    Greenfield, Alex
    Wadhawan, Samir
    Shevell, Diane
    Thompson, John
    Jarap, Gabor
    Christian, Rose
    Sanyal, Arun J.
    HEPATOLOGY, 2018, 68 : 759A - 759A
  • [9] CLINICAL AND HISTOLOGICAL DETERMINANTS OF NONALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED FIBROSIS IN THE ELDERLY
    Noureddin, Mazen
    Vaughn, Ivana A.
    Neuschwander-Tetri, Brent A.
    Sanyal, Arun J.
    McCullough, Arthur J.
    Merriman, Raphael B.
    Yates, Katherine P.
    Tonascia, James
    Unalp-Arida, Aynur
    Doo, Edward
    Kleiner, David E.
    Behling, Cynthia A.
    Loomba, Rohit
    HEPATOLOGY, 2011, 54 : 1118A - 1118A
  • [10] Clinical and biochemical predictors of advanced hepatic fibrosis in nonalcoholic steatohepatitis (NASH).
    Chitturi, S
    Fung, C
    Farrell, GC
    Samarasinghe, D
    Lin, R
    Liddle, C
    George, J
    HEPATOLOGY, 2000, 32 (04) : 535A - 535A
12345